FDA Approves Likmez Metronidazole Oral Suspension 

The Food and Drug Administration (FDA) has approved Likmez™, a ready-to-use liquid suspension formulation of metronidazole.

Likmez oral suspension is supplied in a 200mL bottle containing 500mg/5mL of metronidazole in a strawberry peppermint flavor. The product does not require refrigeration.

Likmez is indicated for the treatment of:

• Symptomatic trichomoniasis caused by Trichomonas vaginalis in adult females and males when the diagnosis is confirmed.
• Asymptomatic trichomoniasis caused by Trichomonas vaginalis in adult females when the organism is associated with endocervicitis, cervicitis, or cervical erosion.
• Acute intestinal amebiasis (amoebic dysentery) and amebic liver abscess in adults and pediatric patients.
• Serious infections caused by susceptible anaerobic bacteria in adults.

“Difficulty swallowing tablets and capsules should not be a barrier to accessing appropriate antibiotic therapy,” said Don Cilla, PharmD, MBA, Appili’s President and CEO. “Likmez provides a convenient alternative for patients who have difficulty taking solid oral medicines.”